NCT06952660 2026-03-12Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical CancerPfizerPhase 4 Recruiting100 enrolled
NCT06586957 2026-02-11A Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsNiKang Therapeutics, Inc.Phase 1 Recruiting150 enrolled
NCT06264921 2025-09-25A Study With NKT3447 for Adults With Advanced/Metastatic Solid TumorsNiKang Therapeutics, Inc.Phase 1 Terminated23 enrolled
NCT06692166 2024-11-22A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical CancerMabwell (Shanghai) Bioscience Co., Ltd.Phase 3 Recruiting420 enrolled
NCT05001282 2024-08-07A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)Elucida OncologyPhase 1/2 Terminated79 enrolled
NCT02164461 2024-05-20Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical CancerAdvaxis, Inc.Phase 1 Completed12 enrolled 18 charts
NCT02139267 2017-07-12Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial NeoplasiaGenexine, Inc.Phase 2 Completed72 enrolled
NCT01379534 2015-05-20A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial CancerNovartisPhase 2 Completed53 enrolled 10 charts
NCT00561795 2012-03-22Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological TumorsGlaxoSmithKlinePhase 2 Completed12 enrolled 6 charts